Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS

ConclusionsResults demonstrated that BGF MDI showed benefits on lung function (vs inhaled corticosteroid/long-acting β2-agonist), as well as symptoms and exacerbations relative to dual therapies. Findings support BGF MDI use in Chinese patients with moderate to very severe COPD.Clinical Trial RegistrationClinicalTrials.gov NCT02497001.

http://link.springer.com/10.1007/s12325-020-01266-5

Source: Advances in Therapy - March 5, 2020 Category: Drugs & Pharmacology Source Type: research